Shares of Q32 Bio QTTB lost nearly 77% yesterday after it reported mixed results from two separate phase IIa studies evaluating its investigational drug bempikibart one in atopic dermatitis (AD or ...

Oppenheimer lowered the firm’s price target on Q32 Bio (QTTB) to $20 from $80 and keeps an Outperform rating on the shares.

Q32 Bio Inc (QTTB) stock saw a decline, ending the day at $5.95 which represents a decrease of $-18.46 or -75.62% from the prior close of $24.41. The stock opened at $8 and touched a low of $5.8 ...

Fintel reports that on December 11, 2024, Wells Fargo downgraded their outlook for Q32 Bio (NasdaqGM:QTTB) from Overweight to Equal-Weight. Analyst Price Forecast Suggests 1,360.58% Upside As of ...

US clinical-stage biotech Q32 Bio (Nasdaq: QTTB) saw its shares plunge 75.6% to $5.59 yesterday, after providing a mixed ...

December 12, 2024 • In 2012, Karam Shaar had to leave his home country of Syria due to the civil war. But he still wanted to make a difference. Through his economic analysis, he uncovered ...

Hindustan Bio Sciences Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 10.72 Crore) operating in Miscellaneous sector. Hindustan Bio Sciences Ltd. key ...

Canada Post, union still at odds as strike nears 1 month Canada Post, union still at odds as strike nears 1 month Canada Post says the latest offer from the union representing its striking workers ...

European Space Agency launches Proba-3 to create an artificial solar eclipse and study the sun’s atmosphere, the corona.

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...

US Bankers Are Cautious Towards Cryptos Despite Upcoming Pro-Crypto Administration ...